Payer Denials

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA kept 2026 volume guidance, but exchange attrition and uninsured growth are turning payer mix and denials into the operational battleground.

From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Turning Denial Data Into Action: How Healthcare Organizations Can Fight Back Against Payer Denials

Healthcare providers across the U.S. are facing a growing wave of claim denials that is putting pressure on already strained hospital finances. Industry research from the American Hospital Association shows that nearly 15% of medical claims submitted to private payers are initially denied, forcing hospitals and health systems to spend about $19.7 billion annually attempting…

Navigating Payer Denials: A Physician Advisor’s Perspective #2

A physician advisor recently described a case that should unsettle anyone who cares about fair, clinically grounded coverage decisions: a Medicaid patient arrived comatose from an overdose, was emergently intubated, developed aspiration pneumonia, and stayed through three midnights before leaving against medical advice. By any bedside standard, this is acute, unstable care—exactly what…

Mastering Revenue Cycle Management: The Key to Thriving in Dallas-Fort Worth’s Healthcare Boom

Healthcare leaders in Dallas-Fort Worth are discovering that optimized revenue cycles unlock competitive advantage in one of the nation's fastest-growing medica